PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells

Author： Al-Hujaily Ensaf   Mohamed Ameera   Al-Sharif Ibtehaj   Youssef Khairia   Manogaran Pulicat   Al-Otaibi Basem   Al-Haza’a Amal   Al-Jammaz Ibrahim   Al-Hussein Khaled   Aboussekhra Abdelilah  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.128, Iss.1, 2011-07, pp. : 97-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells

By        

International Journal of Oncology, Vol. 41, Iss. 3, 2012-01 ,pp. : 1119-1127

Spandidos Publications

Access to resources Recommend Favorite

Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells

By        

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 2057-2065

Spandidos Publications

Access to resources Recommend Favorite

RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ERnegative breast cancer models

By        

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1723-1732

Spandidos Publications

Access to resources Recommend Favorite

Population-based survival-cure analysis of ER-negative breast cancer

By Huang Lan  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 257-264

Springer Publishing Company

Access to resources Recommend Favorite

Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer

By Hoesel Anneke  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 859-869

Springer Publishing Company

Access to resources Recommend Favorite